Acceptability of and preferences for long-acting injectable hormonal contraception among US women: Evidence from a national cross-sectional online survey
Document Type
Article (peer-reviewed)
Publication Date
7-25-2025
Abstract
Background: Long-acting injectable (LAI) hormonal contraception offers a promising approach to meet women’s pregnancy prevention needs. We sought to understand acceptability of and preferences for LAI hormonal contraception among US women, to optimize the design of a sustained-release LAI in development – including which durations to pursue. Methods: We implemented a national cross-sectional online survey including a discrete choice experiment (DCE) with women ages 18–44 years currently using or interested in using contraception. Recruitment was via Prime Panels. DCE attributes included potential duration of effectiveness (6/12/24-months), effect on menses, side effects, and timing of return-to-fertility after use. We used mixed-multinomial logit models to analyze the data. Results: Women (n = 1,029) were 28.6 years old on-average, from 49 US states. 30.9% were Black/African American; 11.6% Hispanic/Latina. 71.6% were nulliparous; 49.0% did not want a(nother) child. Common current contraceptive methods were birth control pills (37.4%), male condoms (35.7%), and withdrawal (19.8%); 18.9% reported having had an unintended pregnancy. In the DCE, women had strong negative preferences for: may cause heavier/unpredictable periods, mild headaches/nausea, slight weight gain, and delayed return-to-fertility (6–12 vs. 3 months), and positive preferences for: may cause no period, and shorter/lighter periods (all p < 0.001). Women also preferred the 12-month to the 6-month duration (p = 0.03). When asked directly about their interest in an LAI with no/minimal side effects/effects on menses and quick return-to-fertility, 92.4% expressed interest, with two-thirds preferring a longer duration (12 or 24-months), and one-third the 6-month duration. Preference for the 6-month duration (vs. 12 or 24) was most highly associated with wanting a child within five years, and higher discomfort with hormones (both p < 0.001). Conclusions: US women report high interest in an LAI. Interest substantially decreases if the LAI may cause unwanted effects such as heavier/unpredictable periods, mild headaches/nausea, slight weight gain, or delayed return-to-fertility. While longer duration (12 + months) is preferred overall, having a 6-month option appears important especially for women who may want to get pregnant within the next few years, and those concerned about hormones (to try it before using a longer duration).
Recommended Citation
Gottert, Ann, Timothy Abuya, Elizabeth Proos, Isabella Johnson, Nathan H. Dormer, Ulrike Foley, Grace Saul, Lisa Haddad, and David R. Friend. 2025. "Acceptability of and preferences for long-acting injectable hormonal contraception among US women: Evidence from a national cross-sectional online survey," Contraception and Reproductive Medicine 10: Article 43.
DOI
10.1186/s40834-025-00380-5
Language
English
